The ERA-NET TRANSCAN-2 project successfully closed on June 30^th, 2021 

The action is continuing with the ERA-NET TRANSCAN-3: Sustained collaboration of national and regional programmes in cancer research, funded by the European Commission under Horizon 2020 from 2021 to 2026 (Grant Agreement no. 964264).

TRANSCAN-3 JOINT TRANSNATIONAL CALL 2022

on the topic:
 "Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy"  

is open for submission

Please visit the TRANSCAN-3 website at

https://transcan.eu/funding/calls/joint-call-jtc-2022-.kl

and follow us on:

Some of the TRANSCAN-2 funded projects are still ongoing and the individual project webpages will be continuously updated.

ERA-NET TRANSCAN-2

The ERA-NET: Aligning national/regional translational cancer research programmes and activities - TRANSCAN-2 is a project funded by the European Commission under the EU framework programme Horizon2020 (Grant Agreement no. 643638) from 2015 to 2021.

It is the continuation of the previous ERA-NET on translational cancer research TRANSCAN, funded under the FP7 from 2011 to 2014.

TRANSCAN-2 is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research. The network is composed of 31 partners from 19 Countries.

 Coordination:
The project is coordinated by the Ministry of Health, Italy
Coordinator: Dr. Giovanni Leonardi. Deputy coordinator: Dr. Gaetano Guglielmi

Contact:
Dr. Silvia Paradisi
Project Manager
Italian National Institute of Health
Viale Regina Elena, 299
00161 Rome, Italy
 
mail to: This email address is being protected from spambots. You need JavaScript enabled to view it.